Wednesday, February 20, 2013 4:42:39 PM
BIEL went from .0040 to north of 12 cents on absolutely nothing a couple of years ago other than a "hope" for FDA approval. Since then, the product line is dramatically expanded, not out of the FDA game yet, science has improved, device applications (a relatively new category at FDA) are up, so forgive the cheerleading, but why wouldn't the price rise?
Of course this is dilution, but that is a label. The issues are why and why now and therein lie the interesting possible reasons?
I know there are probably double the shares out now, and Whelan has financed the operatiuon through dilution, but if Gro-International is successful and the FDA gets it together, why not 4 cents? Or 40 cents?
The one thing I know is no one knows for sure, especially the cynics and bashers. Would I be very happy at 25 cents? You bet! I was happy before when I sold at between 7 and 8 cents on nothing! No sales, fewer products, no FDA, no Gro-International, no Health Canada approval, zip! Patience is the name of this game as was wisely posted by another.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM